The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
Authors
Keywords
SARS-CoV-2, mRNA vaccines, Receptor-binding domain, Liposomes, Administration route
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 335, Issue -, Pages 449-456
Publisher
Elsevier BV
Online
2021-05-22
DOI
10.1016/j.jconrel.2021.05.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Covid-19 — Navigating the Uncharted
- (2020) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ensuring global access to COVID-19 vaccines
- (2020) Gavin Yamey et al. LANCET
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look
- (2020) Ramya Rangan et al. RNA
- Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
- (2020) Sebastian Ols et al. Cell Reports
- A Thermostable mRNA Vaccine against COVID-19
- (2020) Na-Na Zhang et al. CELL
- Recent advances in mRNA vaccine technology
- (2020) Norbert Pardi et al. CURRENT OPINION IN IMMUNOLOGY
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- COVID-19 and mRNA Vaccines—First Large Test for a New Approach
- (2020) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Evolution of the COVID-19 vaccine development landscape
- (2020) Tung Thanh Le et al. NATURE REVIEWS DRUG DISCOVERY
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine
- (2020) Cindy Hörner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent advances in mRNA vaccine delivery
- (2018) Lu Tan et al. Nano Research
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes
- (2018) Fazhan Wang et al. Frontiers in Pharmacology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started